SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

AEX NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

 GALAPAGOS

Last update : 09/03/2017  >View issuer details

2017.05.17 | 22:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos creates new warrant plan - HTML (w)

2017.05.17 | 22:00 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Galapagos creëert nieuw warrantplan - HTML (w)

2017.05.17 | 07:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos to hold Annual R&D Update 2017 on 20 June - HTML (w)

2017.05.17 | 07:30 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Galapagos houdt haar jaarlijkse R&D Update 2017 op 20 juni - HTML (w)

2017.05.15 | 22:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Seven abstracts on filgotinib accepted by EULAR 2017 - HTML (w)

2017.05.15 | 22:00 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Zeven abstracts over filgotinib geaccepteerd door EULAR 2017 - HTML (w)

2017.05.07 | 16:35 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos presents three posters on filgotinib in Crohn's disease at DDW® 2017 - HTML (w)

2017.05.07 | 16:35 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Galapagos presenteert drie posters over filgotinib in de ziekte van Crohn op DDW® 2017 - HTML (w)

2017.04.29 | 07:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI - HTML (w)

2017.04.29 | 07:30 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Galapagos presenteert op OARSI preklinische data met selectieve ADAMTS-5 remmer GLPG1972 voor artritis - HTML (w)

2017.04.27 | 22:00 | Permanent Information Releases / Sales and Revenues

English version HTML (w) Mail

puce Galapagos reports first quarter 2017 results - HTML (w)

2017.04.27 | 22:00 | Permanent Information Releases / Sales and Revenues

Dutch version HTML (w) Mail

puce Galapagos rapporteert resultaten eerste kwartaal 2017 - HTML (w)

2017.04.25 | 22:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus - HTML (w)

2017.04.25 | 22:00 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Galapagos kondigt nieuwe Fase 2 Proof-of-Concept studie aan met filgotinib in huidziekte CLE - HTML (w)

2017.04.25 | Periodic information / 1st Quarter Information

English version PDF Mail

puce GALAPAGOS : Q1 Report 2017 - PDF (1Mb)

Pages : 1 - 2 - 3 / Doc nb : 38